(Reuters) - The medical technology company said in a U.S. regulatory
filing that it expects to raise net proceeds of about $20.2
milllion from the sale of 1.5 million of its common shares,
assuming an initial public offering price of $17 per share.
Assuming a price of $17 a share, the company would have a
market capitalisation of $897.9 million.
Read more at Reuters.com Government Filings News
filing that it expects to raise net proceeds of about $20.2
milllion from the sale of 1.5 million of its common shares,
assuming an initial public offering price of $17 per share.
Assuming a price of $17 a share, the company would have a
market capitalisation of $897.9 million.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment